tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Michael Higgins, 85 are a BUY (94.44%), 5 are a HOLD (5.56%).
Analyst Michael Higgins, carries an average stock price target met ratio of 50.89% that have a potential upside of 57.41% achieved within 324 days. Previously, Michael Higgins worked at LADENBURG, ROTH MKM.
Michael Higgins’s has documented 165 price targets and ratings displayed on 31 stocks. The coverage was on the Healthcare sector.
Most recent stock forecast was given on MRNS, Marinus Pharmaceuticals at 14-Aug-2024.
Analyst best performing recommendations are on ARCT (ARCTURUS THERAPEUTICS HOLDINGS).
The best stock recommendation documented was for ARCT (ARCTURUS THERAPEUTICS HOLDINGS) at 1/13/2017. The price target of $7 was fulfilled within 4 days with a profit of $6.3 (47.37%) receiving and performance score of 118.42.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 21-Aug-2025
$12
$5.98 (99.34%)
$12
1 months 4 days ago
(22-Jun-2026)
0/5 (0%)
$6.9 (135.29%)
Buy Since 23-Jun-2021
$11
$4.98 (82.72%)
$11
1 years 7 months 22 days ago
(04-Dec-2024)
0/7 (0%)
$6.47 (142.83%)
Buy Since 16-Apr-2024
$20
$13.98 (232.23%)
$20
1 years 9 months 16 days ago
(10-Oct-2024)
0/3 (0%)
$15.05 (304.04%)
Buy Since 17-Sep-2020
$11
$7.51 (215.19%)
2 years 4 months 21 days ago
(05-Mar-2024)
0/3 (0%)
$6.61 (150.57%)
Buy Since 20-Aug-2018
2 years 7 months 14 days ago
(12-Dec-2023)
3/3 (100%)
$-38 (-65.52%)
360
What Year was the first public recommendation made by Michael Higgins?
